Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

Advanced Treatments Create New Prospects for Patients and Their Healthcare Providers New FDA-approved medical treatments can be transformative for patients and families, often providing them with more ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

smart inhalers market report highlights transformative digital innovations in respiratory care, improved patient adherence, and forecasted growth through 2035 ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

A procedure at Arnot Health is looking to help patients who are dealing with breathing issues and is said to be an option in addition to inhalers and medical ...

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...